Antiplatelet drugs and breast cancer risk in a large nationwide Danish case‐control study
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Cancer"
DOI: 10.1002/ijc.34343
Abstract: Low‐dose aspirin has been hypothesized to prevent cancer risk by inhibiting platelet aggregation. However, the anti‐cancer effect of low‐dose aspirin has recently been questioned and its effect on breast cancer development remains unclear. The impact… read more here.
Keywords: dose; breast cancer; cancer risk; antiplatelet drugs ... See more keywords
Establishing a reference range for thromboelastography maximum amplitude in patients administrating with antiplatelet drugs
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.23144
Abstract: We aimed to establish the reference range of thromboelastograph (TEG) maximum amplitude (MA) in patients taking antiplatelet drugs. read more here.
Keywords: maximum amplitude; amplitude patients; antiplatelet drugs; reference range ... See more keywords
Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases.
Sign Up to like & getrecommendations! Published in 2023 at "Medicinal research reviews"
DOI: 10.1002/med.21965
Abstract: The blood platelet plays an important role but often remains under-recognized in several vascular complications and associated diseases. Surprisingly, platelet hyperactivity and hyperaggregability have often been considered the critical risk factors for developing vascular dysfunctions… read more here.
Keywords: options management; drugs potential; therapeutic options; potential therapeutic ... See more keywords
Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Thrombosis and Thrombolysis"
DOI: 10.1007/s11239-019-01893-y
Abstract: One-third to one-half of ischemic strokes occurred in patients taking antiplatelet drugs. The optimal therapeutic strategy for antithrombotic drugs remains uncertain and guidelines provide scarse recommendation. Therefore, aims of our study were to: (i) estimate… read more here.
Keywords: ischemic stroke; antiplatelet drugs; study; epidemiology ... See more keywords
Antiplatelet therapy and future intracerebral hemorrhage in hemodialysis patients with cerebral microbleeds
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Clinical Neuroscience"
DOI: 10.1016/j.jocn.2021.05.068
Abstract: The use of antiplatelet drugs is thought to increase the risk for intracerebral hemorrhage (ICH) in patients with cerebral microbleeds (CMBs). However, hemodialysis (HD) patients have a high prevalence of CMBs and diverse pathologies that… read more here.
Keywords: risk; antiplatelet drugs; intracerebral hemorrhage; antiplatelet ... See more keywords
Btk Inhibitors as First Oral Atherothrombosis-Selective Antiplatelet Drugs?
Sign Up to like & getrecommendations! Published in 2019 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0039-1687877
Abstract: Bruton's tyrosine kinase (Btk) is essential for B cell differentiation and proliferation, but also platelets express Btk. Patients with X-linked agammaglobulinemia due to hereditary Btk deficiency do not show bleeding, but a mild bleeding tendency… read more here.
Keywords: antiplatelet drugs; first oral; inhibitors first; btk ... See more keywords
Clinical pharmacology of antiplatelet drugs
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Clinical Pharmacology"
DOI: 10.1080/17512433.2022.2121702
Abstract: ABSTRACT Introduction Platelets play a key role in arterial thrombosis and antiplatelet therapy is pivotal in the treatment of cardiovascular disease. Current antiplatelet drugs target different pathways of platelet activation and show specific pharmacodynamic and… read more here.
Keywords: clinical pharmacology; pharmacology; platelet activation; antiplatelet ... See more keywords
Full Reversal of Anticoagulants Prior to Cephalomedullary Fixation of Geriatric Hip Fractures May Not Be Necessary.
Sign Up to like & getrecommendations! Published in 2023 at "Journal of orthopaedic trauma"
DOI: 10.1097/bot.0000000000002620
Abstract: OBJECTIVES To examine the relationship between anticoagulant and antiplatelet drugs and surgical blood loss for geriatric patients undergoing cephalomedullary nail fixation of extracapsular proximal femur fractures. DESIGN Multicenter retrospective cohort study using bivariate and multivariable… read more here.
Keywords: patients taking; blood; fixation; antiplatelet drugs ... See more keywords
Overcoming Clopidogrel Resistance: Three Promising Novel Antiplatelet Drugs Developed in China
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000000529
Abstract: Abstract:Clopidogrel is one of the most frequently prescribed drugs worldwide; however, the presence of clopidogrel resistance and high susceptibility to genetic variations and drug interactions are facilitating the development of other antiplatelet drugs. To overcome… read more here.
Keywords: developed china; clopidogrel resistance; antiplatelet drugs; clopidogrel ... See more keywords
Efficacy and safety of new oral anticoagulants combined with antiplatelet drugs in the treatment of coronary heart disease: Systematic evaluation and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Noninvasive Electrocardiology"
DOI: 10.1111/anec.12977
Abstract: To analyze the efficacy and safety of antiplatelet drugs combined with new oral anticoagulants (noac) in the treatment of coronary atherosclerotic heart disease (CAD). read more here.
Keywords: heart disease; oral anticoagulants; efficacy safety; antiplatelet drugs ... See more keywords
Efficacy and safety of non-vitamin K antagonist oral anticoagulants combined with antiplatelet drugs for patients with peripheral artery disease: A systematic review and meta-analysis of randomized controlled trials.
Sign Up to like & getrecommendations! Published in 2021 at "Vascular"
DOI: 10.1177/17085381211003694
Abstract: BACKGROUND The efficacy and safety of non-vitamin K antagonist oral anticoagulants (NOACs) combined with antiplatelet drugs in patients with peripheral artery disease remain largely unknown. OBJECTIVE The aim of this meta-analysis was to explore the… read more here.
Keywords: combined antiplatelet; peripheral artery; antiplatelet drugs; artery disease ... See more keywords